Table 5. Characteristics of Patients with Adrenal Cushing Syndrome with Pituitary Adenoma.
| Patient no. | Sex | Age, yr | ACTH, pmol/L | HDST, % | DHEA-S, nmol/L | Adrenal mass, mma | Pituitary mass, mma | |
|---|---|---|---|---|---|---|---|---|
| Serum cortisol | UFC | |||||||
| 1 | F | 24 | 8.4 | 29.0 | 14 | 665 | 37 | 4 |
| 2 | F | 33 | 3.5 | 19.0 | -152 | 510 | 27 | 7 |
| 3 | F | 21 | 8.4 | -29.0 | 10 | 8,717 | 10 | 4 |
| 4 | F | 27 | 2.0 | -64.0 | -467 | 185 | 27 | 3 |
| 5 | F | 51 | 4.8 | -111.0 | 11 | - | 32 | 4 |
| 6 | M | 40 | 5.4 | -1.3 | -10 | 1,878 | 30 | 3 |
| 7 | F | 40 | 4.4 | - | - | - | 10 | 2 |
| 8 | M | 53 | 1.8 | - | -17 | 2,464 | 10 | 3 |
| 9 | M | 57 | 3.7 | 6.7 | -36 | - | 20 | 5 |
In the HDST, % indicates percentage suppression of serum cortisol and UFC after HDST.
ACTH, adrenocorticotropic hormone; HDST, high-dose dexamethasone suppression test; UFC, urine free cortisol; DHEA-S, dehydroepiandrosterone sulfate.
aLongest diameter of mass.